AU2474095A - Synthesis of proteins by native chemical ligation - Google Patents
Synthesis of proteins by native chemical ligationInfo
- Publication number
- AU2474095A AU2474095A AU24740/95A AU2474095A AU2474095A AU 2474095 A AU2474095 A AU 2474095A AU 24740/95 A AU24740/95 A AU 24740/95A AU 2474095 A AU2474095 A AU 2474095A AU 2474095 A AU2474095 A AU 2474095A
- Authority
- AU
- Australia
- Prior art keywords
- ligation
- native
- proteins
- full length
- native chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
- C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
Abstract
Proteins of moderate size having native peptide backbones are produced by a method of native chemical ligation. Native chemical ligation employs a chemoselective reaction of two unprotected peptide segments to produce a transient thioester-linked intermediate. The transient thioester-linked intermediate then spontaneously undergoes a rearrangement to provide the full length ligation product having a native peptide bond at the ligation site. Full length ligation products are chemically identical to proteins produced by cell free synthesis. Full length ligation products may be refolded and/or oxidized, as allowed, to form native disulfide-containing protein molecules. The technique of native chemical ligation is employable for chemically synthesizing full length proteins.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1995/005668 WO1996034878A1 (en) | 1995-05-04 | 1995-05-04 | Synthesis of proteins by native chemical ligation |
CA002218620A CA2218620C (en) | 1995-05-04 | 1995-05-04 | Synthesis of proteins by native chemical ligation |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2474095A true AU2474095A (en) | 1996-11-21 |
AU711451B2 AU711451B2 (en) | 1999-10-14 |
Family
ID=25679740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU24740/95A Expired AU711451B2 (en) | 1995-05-04 | 1995-05-04 | Synthesis of proteins by native chemical ligation |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0832096B1 (en) |
JP (1) | JP3599346B2 (en) |
AT (1) | ATE203248T1 (en) |
AU (1) | AU711451B2 (en) |
CA (1) | CA2218620C (en) |
DE (1) | DE69521815T2 (en) |
DK (1) | DK0832096T3 (en) |
ES (1) | ES2161885T3 (en) |
GR (1) | GR3036895T3 (en) |
MX (1) | MX9708500A (en) |
PT (1) | PT832096E (en) |
SI (1) | SI0832096T1 (en) |
WO (1) | WO1996034878A1 (en) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6184344B1 (en) * | 1995-05-04 | 2001-02-06 | The Scripps Research Institute | Synthesis of proteins by native chemical ligation |
US6307018B1 (en) * | 1996-12-24 | 2001-10-23 | The Scripps Research Institute | General chemical ligation |
JP2001512306A (en) | 1997-01-08 | 2001-08-21 | ライフ テクノロジーズ,インコーポレイテッド | Methods for producing proteins |
EP1518862B1 (en) * | 1997-06-13 | 2007-02-21 | Gryphon Therapeutics, Inc. | Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution |
EP1001968B1 (en) | 1997-06-13 | 2004-12-22 | Gryphon Therapeutics, Inc. | Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution |
US6168784B1 (en) | 1997-09-03 | 2001-01-02 | Gryphon Sciences | N-terminal modifications of RANTES and methods of use |
AU750244B2 (en) | 1997-09-04 | 2002-07-11 | Gryphon Sciences | Modular protein libraries and methods of preparation |
US6875594B2 (en) * | 1997-11-13 | 2005-04-05 | The Rockefeller University | Methods of ligating expressed proteins |
KR20010085743A (en) | 1998-08-31 | 2001-09-07 | 추후제출 | Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
AUPP589598A0 (en) | 1998-09-14 | 1998-10-08 | University Of Queensland, The | Novel peptides |
US6365377B1 (en) | 1999-03-05 | 2002-04-02 | Maxygen, Inc. | Recombination of insertion modified nucleic acids |
US7192713B1 (en) | 1999-05-18 | 2007-03-20 | President And Fellows Of Harvard College | Stabilized compounds having secondary structure motifs |
US7482425B2 (en) | 1999-08-26 | 2009-01-27 | Amylin Pharmaceuticals, Inc. | Compositions for lipid matrix-assisted chemical ligation |
US6277957B1 (en) * | 2000-03-23 | 2001-08-21 | Derek Hudson | Method for production of acylthio derivatives |
AU2001269906A1 (en) * | 2000-06-19 | 2002-01-02 | Zyomyx, Inc. | Methods for immobilizing polypeptides |
JP2004507557A (en) * | 2000-09-01 | 2004-03-11 | グリフォン セラピューティクス,インコーポレーテッド | Nucleophilically stable thioester-forming compounds, methods of manufacture and use |
RU2003109746A (en) * | 2000-09-08 | 2005-01-27 | Грифон Терапьютикс, Инк. (Us) | SYNTHETIC PROTEINS STIMULATING ERYTHROPOESIS |
GB0113657D0 (en) * | 2001-06-05 | 2001-07-25 | Geneprot Inc | Improved native chemical ligation with three or more components |
GB0123262D0 (en) * | 2001-09-27 | 2001-11-21 | Adprotech Ltd | Polymeric compounds |
US6908963B2 (en) | 2001-10-09 | 2005-06-21 | Nektar Therapeutics Al, Corporation | Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith |
AU2003214068A1 (en) * | 2002-02-19 | 2003-09-09 | Rmf Dictagene S.A. | Method for producing interferon |
WO2004061094A1 (en) | 2002-12-30 | 2004-07-22 | Gryphon Therapeutics, Inc. | Water-soluble thioester and selenoester compounds and methods for making and using the same |
DE10335584B4 (en) | 2003-07-31 | 2006-06-29 | Philipps-Universität Marburg | Process for the preparation of cyclic molecules |
US7635750B2 (en) | 2003-09-05 | 2009-12-22 | Sloan-Kettering Institute For Cancer Research | Method for preparing polyfunctionalized peptides and/or proteins via native chemical ligation |
PT1680443E (en) | 2003-11-05 | 2013-12-11 | Harvard College | Stabilized alpha helical peptides and uses thereof |
EP2010556B1 (en) | 2006-04-11 | 2015-09-23 | Sloan-Kettering Institute for Cancer Research | Homogeneous erythropoietin and method for their preparation |
EP2628749A3 (en) * | 2006-06-20 | 2013-12-04 | Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | Antimicrobial kinocidin compostions and methods of use |
WO2008076904A1 (en) | 2006-12-14 | 2008-06-26 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
AU2008210434C8 (en) | 2007-01-31 | 2014-03-27 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
WO2008104000A2 (en) | 2007-02-23 | 2008-08-28 | Aileron Therapeutics, Inc. | Triazole macrocycle systems |
BRPI0809366B8 (en) | 2007-03-28 | 2021-05-25 | Harvard College | substantially alpha-helical polypeptide, method for manufacturing same, amino acid and pharmaceutical composition |
JP5517620B2 (en) | 2007-07-31 | 2014-06-11 | 株式会社糖鎖工学研究所 | Method for producing peptide |
EP2356139A4 (en) | 2008-07-23 | 2013-01-09 | Harvard College | Ligation of stapled polypeptides |
BRPI0917298B8 (en) | 2008-08-19 | 2021-05-25 | Glytech Inc | glycoprotein production method and glycoprotein tracking method |
EP2342221B1 (en) | 2008-09-22 | 2018-11-07 | Aileron Therapeutics, Inc. | Methods for preparing purified polypeptide compositions |
WO2010083347A2 (en) | 2009-01-14 | 2010-07-22 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
WO2010087994A2 (en) | 2009-01-30 | 2010-08-05 | Whitehead Institute For Biomedical Research | Methods for ligation and uses thereof |
TW201031749A (en) | 2009-02-10 | 2010-09-01 | Otsuka Chemical Co Ltd | IgG-Fc fragment and method for manufacturing the same |
KR101676515B1 (en) | 2009-06-26 | 2016-11-15 | 가부시키가이샤 도우사 고가쿠 겐큐쇼 | Process for production of peptide thioester |
AU2010273220B2 (en) | 2009-07-13 | 2015-10-15 | President And Fellows Of Harvard College | Bifunctional stapled polypeptides and uses thereof |
US20120114595A1 (en) | 2009-07-16 | 2012-05-10 | Otsuka Chemical Co., Ltd. | Sugar chain-added ailim extracellular domain and method for producing same |
CA2774973A1 (en) | 2009-09-22 | 2011-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
FR2952058B1 (en) | 2009-10-29 | 2013-10-04 | Centre Nat Rech Scient | PROCESS FOR NATIVE LIGATION OF POLYPEPTIDES |
US8859723B2 (en) | 2010-08-13 | 2014-10-14 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
US8957026B2 (en) | 2010-09-22 | 2015-02-17 | President And Fellows Of Harvard College | Beta-catenin targeting peptides and uses thereof |
FR2971509B1 (en) | 2011-02-16 | 2013-02-22 | Centre Nat Rech Scient | PROCESS FOR PREPARING PEPTIDES BY ASSEMBLING MULTIPLE PEPTIDE FRAGMENTS |
US9073978B2 (en) | 2011-03-10 | 2015-07-07 | Glytech, Inc. | Method for producing glycopeptide having sialyl sugar chain, sialyl sugar chain-added amino acid derivative to be used in same, and glycopeptide |
WO2012174423A1 (en) | 2011-06-17 | 2012-12-20 | President And Fellows Of Harvard College | Stabilized polypeptides as regulators of rab gtpase function |
JP6186278B2 (en) | 2011-09-26 | 2017-08-23 | 株式会社糖鎖工学研究所 | Efficient production method of polypeptide fragment suitable for NCL method |
FR2981352B1 (en) | 2011-10-17 | 2015-07-03 | Centre Nat Rech Scient | PROCESS FOR PROTEIN SYNTHESIS |
CN108929375A (en) | 2011-10-18 | 2018-12-04 | 爱勒让治疗公司 | Peptidomimetic macrocyclic compound |
US8927500B2 (en) | 2012-02-15 | 2015-01-06 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
US8987414B2 (en) | 2012-02-15 | 2015-03-24 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
FR2988392B1 (en) | 2012-03-21 | 2014-04-11 | Centre Nat Rech Scient | NATIVE LIGATION METHOD |
HUE054444T2 (en) | 2012-09-26 | 2021-09-28 | Harvard College | Proline-locked stapled peptides and uses thereof |
JP6526563B2 (en) | 2012-11-01 | 2019-06-05 | エイルロン セラピューティクス,インコーポレイテッド | Disubstituted amino acids and methods for their preparation and use |
KR20150131244A (en) | 2013-03-13 | 2015-11-24 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | Stapled and stitched polypeptides and uses thereof |
CN105492460A (en) | 2013-06-14 | 2016-04-13 | 哈佛大学的校长及成员们 | Stabilized polypeptide insulin receptor modulators |
CN106573032B (en) | 2014-05-21 | 2022-03-18 | 哈佛大学的校长及成员们 | RAS inhibitory peptides and uses thereof |
US10905739B2 (en) | 2014-09-24 | 2021-02-02 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and formulations thereof |
SG10201902594QA (en) | 2014-09-24 | 2019-04-29 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof |
MX2017011834A (en) | 2015-03-20 | 2018-04-11 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof. |
WO2017004548A1 (en) | 2015-07-01 | 2017-01-05 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
EP3347372A4 (en) | 2015-09-10 | 2019-09-04 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles as modulators of mcl-1 |
AU2018228182B2 (en) | 2017-03-02 | 2024-04-11 | Glytech, Inc. | Production method for amino-acid polymer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1228537B (en) * | 1987-07-30 | 1991-06-20 | Magis Farmaceutici | EXISTING ACTION CISTEIN DERIVATIVES |
CA2015938C (en) * | 1989-05-02 | 1999-09-07 | Kevin M. Knigge | Covalent attachment of specific binding members to a solid phase |
-
1995
- 1995-05-04 JP JP53326196A patent/JP3599346B2/en not_active Expired - Lifetime
- 1995-05-04 SI SI9530522T patent/SI0832096T1/en unknown
- 1995-05-04 EP EP95919029A patent/EP0832096B1/en not_active Expired - Lifetime
- 1995-05-04 ES ES95919029T patent/ES2161885T3/en not_active Expired - Lifetime
- 1995-05-04 AT AT95919029T patent/ATE203248T1/en active
- 1995-05-04 AU AU24740/95A patent/AU711451B2/en not_active Expired
- 1995-05-04 CA CA002218620A patent/CA2218620C/en not_active Expired - Lifetime
- 1995-05-04 PT PT95919029T patent/PT832096E/en unknown
- 1995-05-04 WO PCT/US1995/005668 patent/WO1996034878A1/en active IP Right Grant
- 1995-05-04 DK DK95919029T patent/DK0832096T3/en active
- 1995-05-04 MX MX9708500A patent/MX9708500A/en active IP Right Grant
- 1995-05-04 DE DE69521815T patent/DE69521815T2/en not_active Expired - Lifetime
-
2001
- 2001-10-16 GR GR20010401765T patent/GR3036895T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
DK0832096T3 (en) | 2001-10-01 |
PT832096E (en) | 2002-01-30 |
CA2218620C (en) | 2007-02-27 |
EP0832096A1 (en) | 1998-04-01 |
CA2218620A1 (en) | 1996-11-07 |
AU711451B2 (en) | 1999-10-14 |
GR3036895T3 (en) | 2002-01-31 |
EP0832096A4 (en) | 1998-08-05 |
ES2161885T3 (en) | 2001-12-16 |
EP0832096B1 (en) | 2001-07-18 |
DE69521815T2 (en) | 2002-04-04 |
JPH11508874A (en) | 1999-08-03 |
MX9708500A (en) | 1998-02-28 |
JP3599346B2 (en) | 2004-12-08 |
WO1996034878A1 (en) | 1996-11-07 |
SI0832096T1 (en) | 2001-12-31 |
ATE203248T1 (en) | 2001-08-15 |
DE69521815D1 (en) | 2001-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2474095A (en) | Synthesis of proteins by native chemical ligation | |
AU3503795A (en) | Synthesis of proteins by native chemical ligation calicheamicin mimics | |
AU5055593A (en) | Antibodies specific for HIV | |
DE69732640D1 (en) | SOLID PHASE PEPTIDE SYNTHESIS | |
ATE361364T1 (en) | ANTIBODIES TO THE ED-B DOMAIN OF FIBRONECTIN, THEIR PRODUCTION AND USES | |
AU1843395A (en) | Antibody purification | |
ATE270303T1 (en) | GC1Q RECEPTOR, HIV-1 GP120 REGION BINDING TO IT, RELATED PEPTIDES AND ANTIBODIES | |
AU4727593A (en) | Stress protein epitopes | |
AU5733199A (en) | Method for chromatographically purifying insulins | |
EP0801657A4 (en) | Retinoid x receptor-interacting polypeptides and related molecules and methods | |
AU580350B2 (en) | Process for synthesising peptides | |
NO306163B1 (en) | Conversion of bisnoral alcohol to bisnoraldehyde | |
CA2137280A1 (en) | Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications | |
Bennich et al. | The release of Fc′ and pFc′ fragments from human immunoglobulin G following enzymic digestion: a time study | |
AU7334291A (en) | Merosin, nucleic acids encoding, fragments and uses thereof | |
CA2092062A1 (en) | Peptide synthesis process and novel synthesis intermediates | |
AU5312096A (en) | Immunoassay using antibodies directed to the reaction product of enzymes used as labels | |
ATE200678T1 (en) | UROGENITAL CARCINOMA TLP PEPTIDE COMPLEX AND DERIVED ANTIBODIES | |
MX9700941A (en) | Icam-4 materials and methods. | |
ATE209658T1 (en) | SYNTHETIC PROTEIN BUILT USING A TEMPLATE | |
KR870005008A (en) | Method for preparing 4'-O-tetrahydropyranyl adriamycin b | |
DE69616029T2 (en) | SYNTHESIS OF (+) - PANCRATISTATIN | |
Aukamp, PJ* & Holzapfel | Toxic substances from Aspergillus versicolor | |
WO2000011032A3 (en) | Method for producing biostatin (tt-232 triacetate) and analogs thereof | |
AU7459300A (en) | Process for the preparation of a dipeptide and intermediate product in such a process |